Piperidine renin inhibitors
US8198453B2 · kind B2 · utility
2Cited by
16References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2007 |
| Grant date | Jun 12, 2012 |
| Priority date | — |
| Expiry date | Jul 28, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to aspartic protease inhibitors represented by the following structural formula (I), or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the aspartic protease inhibitors of Structural Formula (I). Methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using these aspartic protease inhibitors are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.